Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Abbott : Declares 390th Consecutive Quarterly Dividend

06/11/2021 | 11:20am EDT

ABBOTT PARK, Ill., June 11, 2021 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 45 cents per share.

This marks the 390th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 16, 2021, to shareholders of record at the close of business on July 15, 2021.

Abbott has increased its dividend payout for 49 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.

About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at http://www.facebook.com/Abbott and on Twitter @AbbottNews.

 

Cision
View original content:http://www.prnewswire.com/news-releases/abbott-declares-390th-consecutive-quarterly-dividend-301310931.html

SOURCE Abbott


© PRNewswire 2021
All news about ABBOTT LABORATORIES
07/30ABBOTT LABORATORIES : - half of americans living with diabetes may be consuming ..
AQ
07/29NEW STUDY : Half of Americans Living with Diabetes May be Consuming Less Than th..
PR
07/27Global markets live: LVMH, Michelin, Tesla, Amazon, Activision...
07/23ABBOTT LABORATORIES : Jefferies & Co Adjusts Abbott Laboratories PT to $135 From..
MT
07/23ABBOTT LABORATORIES : JPMorgan Adjusts Abbott Laboratories PT to $135 From $122,..
MT
07/23ABBOTT LABORATORIES : Morgan Stanley Adjusts Abbott Laboratories PT to $136 From..
MT
07/23ABBOTT LABORATORIES : Raymond James Adjusts Price Target on Abbott Laboratories ..
MT
07/23ABBOTT LABORATORIES : Credit Suisse Raises Abbott Laboratories' PT to $130 from ..
MT
07/23ABBOTT LABORATORIES : UBS Adjusts Abbott Laboratories' PT to $131 From $127, Cit..
MT
07/23ANALYST RECOMMENDATIONS : Apple, Aviva, Biogen, Comerica Incorporated, Tesla...
More news